Royalty Pharma Sub-Manager, LLC
Follow13F filer, CIK 2081668, New York, NY
Royalty Pharma Sub-Manager, LLC reported $196,268,588 across 4 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13.
Accepted , ingested 13F-HR 0002081668-26-000021
- Period
- 2026-09-30
- Reported value
- $196M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Part of the filer group Royalty Pharma Sub-Manager, LLC
How groups are builtHoldings, Q3 2026
Share positions as resolved from 13F-HR 0002081668-26-000021, largest first. % of portfolio is the value over $196,268,588, the sum of the share positions whose value is usable for ratios (method).
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002081668-26-000021 | base | 2026-11-13 |